New patent for Apellis Pharms drug SYFOVREBy DrugPatentWatch – Make Better Decisions / March 21, 2024 Annual Drug Patent Expirations for SYFOVRE Syfovre is a drug marketed by Apellis Pharms and is included in one NDA. It is available from one supplier. There are ten patents…Source